Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Eli Lilly, weight loss

Digest more
Straight Arrow News on MSN · 1d
Eli Lilly touts strong results of new experimental weight loss drug retatrutide
Move over Ozempic, Wegovy, Mounjaro and Zepbound - Eli Lilly says another contender may be on the way. The pharmaceutical giant announced encouraging results from a Phase 3 clinical trial of its experimental weight loss drug retatrutide,

Continue reading

 · 1d · on MSN
Lilly's next-gen drug shows greater weight loss than Zepbound in late-stage trial
Zacks Investment Research on MSN · 1d
Eli Lilly's next-generation obesity drug secures first phase III win
2d

A better Ozempic? Eli Lilly’s new obesity drug cut weight by 23%, study finds

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
1d

Novo's Next Shot at Dominance: High-Dose Wegovy Takes Aim at Lilly's Zepbound

Regulators in Europe just backed Novo's heavyweight Wegovy--setting the stage for a head-to-head obesity drug showdown in ...
7don MSN

Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
  • Privacy
  • Terms